Medical Device Contract Manufacturing Market Report 2026

Medical Device Contract Manufacturing Market Overview

• Medical Device Contract Manufacturing market size has reached to $114.66 billion in 2025 • Expected to grow to $228.23 billion in 2030 at a compound annual growth rate (CAGR) of 14.8% • Growth Driver: Rising Prevalence Of Chronic Disorders Driving The Market Growth Due To Aging Populations And Lifestyle Factors • Market Trend: Advanced Development-To-Manufacturing Infrastructure Enhances Innovation Efficiency In Medical Device Contract Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Device Contract Manufacturing Market?

Medical device contract manufacturing refers to a process where a Medtech company that owns the idea (sole proprietorship) outsources manufacturing to another medical device manufacturing firm. The medical device contract manufacturing is used for the benefits of cost optimization, device upgrade, regulatory guidance, or expansion. The main devices of medical device contract manufacturing are IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopaedic devices, dental devices, and other devices. IVD devices refer to medical devices that are in vitro diagnostic medical devices (IVD) that are used alone or in combination with other diagnostic products for in vitro use, apparatus, equipment, or systems. The services are device development and manufacturing services, quality management services, and assembly services. The applications involved laparoscopy, pulmonary, urology, gynecology, and other applications.

What Is The Medical Device Contract Manufacturing Market Growth Forecast?

The medical device contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $228.23 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of advanced manufacturing technologies, rising demand for rapid device commercialization, expansion of personalized and minimally invasive devices, growing focus on supply chain resilience, increasing partnerships between OEMs and CMOs. Major trends in the forecast period include increasing outsourcing of complex device manufacturing, rising demand for end-to-end contract manufacturing services, growing focus on regulatory-compliant production capabilities, expansion of scalable manufacturing infrastructure, enhanced emphasis on quality and risk management.

Global Medical Device Contract Manufacturing Market Segmentation

1) By Device: IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Ophthalmology Devices, Orthopedic Devices, Dental Devices, Other Devices 2) By Service: Device Development and Manufacturing Service, Quality Management Service, Assembly Service 3) By Application: Design And Prototyping, Component Manufacturing, Device Assembly And Integration, Packaging And Sterilization, Quality Assurance And Testing, Regulatory And Compliance Support, Lifecycle Management And Scale-Up Manufacturing Subsegments: 1) By In Vitro Diagnostics (IVD) Devices: Reagents, Test Kits, Assays 2) By Diagnostic Imaging Devices: X-ray Machines, MRI Machines, Ultrasound Equipment 3) By Cardiovascular Devices: Stents, Catheters, Pacemakers 4) By Drug Delivery Devices: Infusion Pumps, Nebulizers, Auto-Injectors 5) By Endoscopy Devices: Flexible Endoscopes, Rigid Endoscopes, Accessories 6) By Ophthalmology Devices: Intraocular Lenses (IOLs), Diagnostic Equipment, Surgical Instruments 7) By Orthopedic Devices: Implants, Surgical Tools, Prosthetics 8) By Dental Devices: Dental Implants, Orthodontic Devices, Dental Chairs 9) By Other Devices: Surgical Instruments, Monitoring Devices, Wearable Health Tech

What Is The Driver Of The Medical Device Contract Manufacturing Market?

The rising prevalence of chronic disorders is expected to propel the growth of the medical device contract manufacturing market going forward. Chronic disorders refer to long-term health conditions such as cardiovascular diseases, diabetes, and respiratory diseases that persist over extended periods and often require continuous medical management and monitoring. The rising prevalence of chronic disorders is driven by aging populations and lifestyle factors, as increasing life expectancy combined with sedentary behaviors, poor dietary habits, and limited physical activity contribute to higher incidence rates of chronic health conditions. Growing chronic disorder prevalence supports increased demand for specialized medical devices including monitoring equipment, implantable devices, and diagnostic tools that healthcare providers require to manage these long-term conditions effectively. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), an US-Based organization reported that 76.4?percent of U.S. adults (about 194?million) reported having at least one chronic condition, and 51.4?percent (about 130?million) reported having two or more chronic conditions. Therefore, the rising prevalence of chronic disorders is driving the growth of the medical device contract manufacturing industry.

Key Players In The Global Medical Device Contract Manufacturing Market

Major companies operating in the medical device contract manufacturing market are Phillips-Medisize Corporation, Integer Holdings Corporation, Flex Ltd, Sanmina Corporation, Plexus Corporation, Benchmark Electronics Inc, Celestica International LP, Jabil Inc, Kimball Electronics Inc, Nortech Systems Inc, Gerresheimer AG, Catalent Inc, Nemera Development S.A., Consort Medical plc, Invetech, SteriPack Group Ltd, Forefront Medical Technologies Pte Ltd, Nipro Corporation, TE Connectivity Ltd, West Pharmaceutical Services Inc

Global Medical Device Contract Manufacturing Market Trends and Insights

Major companies operating in the medical device contract manufacturing market are focusing on developing innovative initiatives such as integrated new product introduction (NPI) platforms to accelerate device development and ensure seamless transfer to large-scale manufacturing. Integrated new product introduction (NPI) platforms are end-to-end systems that combine design, prototyping, testing, and manufacturing readiness into a single streamlined process, helping medical device companies reduce development time, improve quality control, minimize production risks, and accelerate the transition from concept to full-scale manufacturing. For instance, in March 2025, Flex Ltd., a US-based manufacturing company, launched its new NPI Center near Boston, one of the world’s leading medtech innovation hubs. Designed to enhance end-to-end product realization, the center features an 8,000 ft² development lab equipped for simultaneous prototype and preclinical builds, alongside a 2,000 ft² validation and quality testing space, and is slated for ISO 13485 certification by Q2 2025. Supporting applications across surgical robotics, medical devices, imaging systems, and laboratory diagnostics, the facility enables OEMs to reduce development risk, shorten time-to-market, and leverage an integrated manufacturing ecosystem.

What Are Latest Mergers And Acquisitions In The Medical Device Contract Manufacturing Market?

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Binding Site Group for approximately $2.8 billion. As a result of the acquisition, The Binding Site enhances Thermo Fisher's specialty diagnostics portfolio by introducing groundbreaking innovations in diagnostics and monitoring for multiple myeloma. This expansion supports earlier diagnosis and more informed treatment decisions, improving patient outcomes. Thermo Fisher is eager to drive further advancements in this field for the benefit of patients. Binding Site Group is a UK-based company specializing in medical device contract manufacturing.

Regional Outlook

North America will be the largest region in the medical device contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Device Contract Manufacturing Market?

The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.